Clinical outcomes of MED and iLESSYS® Delta for the treatment of lumbar central spinal stenosis and lateral recess stenosis: A comparison study

腰椎管狭窄症 椎管狭窄
作者
Boyu Wu,Chengjie Xiong,Lin-ying Tan,Dongdong Zhao,Feng Xu,Hui Kang
出处
期刊:Experimental and Therapeutic Medicine [Spandidos Publishing]
卷期号:20 (6): 1-1 被引量:6
标识
DOI:10.3892/etm.2020.9382
摘要

Microendoscopic discectomy (MED) is an established procedure used to treat lumbar central spinal stenosis (LCSS) and lateral recess stenosis (LRS). The Interlaminar Endoscopic Surgical System iLESSYS® Delta approach has been developed from the traditional interlaminar endoscopic technique for the treatment of LCSS and LRS. In the present study, MED was used as a reference to evaluate this newly developed approach. A total of 82 and 52 patients with radicular leg pain and/or neurogenic claudication symptoms were treated by spinal canal decompression using the MED or iLESSYS® Delta approach, respectively. The clinical outcomes of the patients were analyzed using the Modified MacNab's criteria, visual analogue scale (VAS) leg pain score, VAS back pain score and the Oswestry Disability Index (ODI) score. Finally, the effectiveness of the decompression was evaluated on a cross-sectional area of the dural sac (CSAD) at the disc level. The incision length in the iLESSYS® Delta group was significantly decreased compared with the MED group (P<0.05); however, the duration of the operation in the iLESSYS® Delta group was significantly longer compared with the MED group (P<0.05). The VAS score of the back and ODI score in the iLESSYS® Delta group were significantly decreased compared with the MED group at the 1-week follow-up (P<0.0125). The postoperative CSAD was also significantly increased in both groups compared with before the operation (P<0.05); however, there were no significant differences in the postoperative CSAD between the two groups. The good-to-excellent rates of the MED and iLESSYS® Delta approach were 89.0 and 90.4%, respectively, whereas the complication rates of the MED and iLESSYS® Delta system were 3.66 and 3.85% in the two groups, respectively. In conclusion, the iLESSYS® Delta approach was identified to be comparable with the MED approach for treating LCSS and LRS, demonstrating both precise and limited decompression. In addition, the iLESSYS® Delta approach may reduce the short-term back pain and promote faster recovery compared with the MED.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
眼睛大的断缘完成签到,获得积分10
刚刚
刚刚
Nexus应助岸部采纳,获得10
1秒前
2秒前
nature完成签到,获得积分10
2秒前
3秒前
叶辰发布了新的文献求助10
4秒前
朝朝完成签到,获得积分10
4秒前
CC发布了新的文献求助10
4秒前
Owen应助哈哈采纳,获得10
4秒前
Wenge完成签到,获得积分10
4秒前
456721发布了新的文献求助10
5秒前
5秒前
6秒前
大气的乌冬面完成签到 ,获得积分10
6秒前
ln发布了新的文献求助10
7秒前
Negroni完成签到,获得积分10
7秒前
这么年轻压根睡不着完成签到 ,获得积分10
7秒前
8秒前
今后应助微眠采纳,获得10
8秒前
Diachurn完成签到 ,获得积分10
9秒前
9秒前
奔跑的蒲公英完成签到,获得积分10
10秒前
青青子衿发布了新的文献求助30
11秒前
氢氦锂铍硼完成签到,获得积分10
11秒前
12秒前
12秒前
搜集达人应助cdhuang采纳,获得10
12秒前
橙鱼完成签到,获得积分20
13秒前
Hxj发布了新的文献求助10
13秒前
13秒前
慕青应助1234采纳,获得10
14秒前
天天快乐应助文具盒采纳,获得10
14秒前
ln完成签到,获得积分20
15秒前
xLi完成签到,获得积分10
15秒前
16秒前
贪玩半仙完成签到,获得积分10
17秒前
YB96完成签到,获得积分10
17秒前
何禾发布了新的文献求助10
17秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
卤化钙钛矿人工突触的研究 2000
Моделирование процессов самоорганизации в кристаллообразующих системах 1000
History of U.S. Space Surveillance and Satellite Cataloging 1000
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6522170
求助须知:如何正确求助?哪些是违规求助? 8315427
关于积分的说明 17789369
捐赠科研通 5624292
什么是DOI,文献DOI怎么找? 2927863
邀请新用户注册赠送积分活动 1904662
关于科研通互助平台的介绍 1764695